These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29963178)

  • 1. S-trityl-L-cysteine, a novel Eg5 inhibitor, is a potent chemotherapeutic strategy in neuroblastoma.
    Wu W; Jingbo S; Xu W; Liu J; Huang Y; Sheng Q; Lv Z
    Oncol Lett; 2018 Jul; 16(1):1023-1030. PubMed ID: 29963178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteome analysis of apoptosis signaling by S-trityl-L-cysteine, a potent reversible inhibitor of human mitotic kinesin Eg5.
    Kozielski F; Skoufias DA; Indorato RL; Saoudi Y; Jungblut PR; Hustoft HK; Strozynski M; Thiede B
    Proteomics; 2008 Jan; 8(2):289-300. PubMed ID: 18186019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docetaxel-resistant prostate cancer cells remain sensitive to S-trityl-L-cysteine-mediated Eg5 inhibition.
    Wiltshire C; Singh BL; Stockley J; Fleming J; Doyle B; Barnetson R; Robson CN; Kozielski F; Leung HY
    Mol Cancer Ther; 2010 Jun; 9(6):1730-9. PubMed ID: 20515952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A potent chemotherapeutic strategy for bladder cancer: (S)-methoxy-trityl-L-cystein, a novel Eg5 inhibitor.
    Ding S; Nishizawa K; Kobayashi T; Oishi S; Lv J; Fujii N; Ogawa O; Nishiyama H
    J Urol; 2010 Sep; 184(3):1175-81. PubMed ID: 20663523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationship of S-trityl-L-cysteine analogues as inhibitors of the human mitotic kinesin Eg5.
    Debonis S; Skoufias DA; Indorato RL; Liger F; Marquet B; Laggner C; Joseph B; Kozielski F
    J Med Chem; 2008 Mar; 51(5):1115-25. PubMed ID: 18266314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eg5 inhibitor, a novel potent targeted therapy, induces cell apoptosis in renal cell carcinoma.
    Ding S; Zhao Z; Sun D; Wu F; Bi D; Lu J; Xing N; Sun L; Wu H; Ding K
    Tumour Biol; 2014 Aug; 35(8):7659-68. PubMed ID: 24801905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S-trityl-L-cysteine is a reversible, tight binding inhibitor of the human kinesin Eg5 that specifically blocks mitotic progression.
    Skoufias DA; DeBonis S; Saoudi Y; Lebeau L; Crevel I; Cross R; Wade RH; Hackney D; Kozielski F
    J Biol Chem; 2006 Jun; 281(26):17559-69. PubMed ID: 16507573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the protein binding region of S-trityl-L-cysteine, a new potent inhibitor of the mitotic kinesin Eg5.
    Brier S; Lemaire D; Debonis S; Forest E; Kozielski F
    Biochemistry; 2004 Oct; 43(41):13072-82. PubMed ID: 15476401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A potent chemotherapeutic strategy in prostate cancer: S-(methoxytrityl)-L-cysteine, a novel Eg5 inhibitor.
    Xing ND; Ding ST; Saito R; Nishizawa K; Kobayashi T; Inoue T; Oishi S; Fujii N; Lv JJ; Ogawa O; Nishiyama H
    Asian J Androl; 2011 Mar; 13(2):236-41. PubMed ID: 21297652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro screening for inhibitors of the human mitotic kinesin Eg5 with antimitotic and antitumor activities.
    DeBonis S; Skoufias DA; Lebeau L; Lopez R; Robin G; Margolis RL; Wade RH; Kozielski F
    Mol Cancer Ther; 2004 Sep; 3(9):1079-90. PubMed ID: 15367702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photocontrol of the mitotic kinesin Eg5 using a novel S-trityl-L-cysteine analogue as a photochromic inhibitor.
    Ishikawa K; Tohyama K; Mitsuhashi S; Maruta S
    J Biochem; 2014 Apr; 155(4):257-63. PubMed ID: 24451491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug resistance dependent on allostery: A P-loop rigor Eg5 mutant exhibits resistance to allosteric inhibition by STLC.
    Indorato RL; DeBonis S; Garcia-Saez I; Skoufias DA
    Front Oncol; 2022; 12():965455. PubMed ID: 36313676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiproliferative
    Radwan MO; Ciftci HI; Ali TFS; Ellakwa DE; Koga R; Tateishi H; Nakata A; Ito A; Yoshida M; Okamoto Y; Fujita M; Otsuka M
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31510043
    [No Abstract]   [Full Text] [Related]  

  • 14. Mutations in the human kinesin Eg5 that confer resistance to monastrol and S-trityl-L-cysteine in tumor derived cell lines.
    Tcherniuk S; van Lis R; Kozielski F; Skoufias DA
    Biochem Pharmacol; 2010 Mar; 79(6):864-72. PubMed ID: 19896928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STLC-resistant cell lines as tools to classify chemically divergent Eg5 targeting agents according to their mode of action and target specificity.
    Indorato RL; DeBonis S; Kozielski F; Garcia-Saez I; Skoufias DA
    Biochem Pharmacol; 2013 Nov; 86(10):1441-51. PubMed ID: 24041742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photocontrol of mitotic kinesin Eg5 facilitated by thiol-reactive photochromic molecules incorporated into the loop L5 functional loop.
    Ishikawa K; Tamura Y; Maruta S
    J Biochem; 2014 Mar; 155(3):195-206. PubMed ID: 24334276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and Thermodynamic Basis of the Enhanced Interaction between Kinesin Spindle Protein Eg5 and STLC-type Inhibitors.
    Yokoyama H; Sawada JI; Sato K; Ogo N; Kamei N; Ishikawa Y; Hara K; Asai A; Hashimoto H
    ACS Omega; 2018 Sep; 3(9):12284-12294. PubMed ID: 31459302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationship and multidrug resistance study of new S-trityl-L-cysteine derivatives as inhibitors of Eg5.
    Kaan HY; Weiss J; Menger D; Ulaganathan V; Tkocz K; Laggner C; Popowycz F; Joseph B; Kozielski F
    J Med Chem; 2011 Mar; 54(6):1576-86. PubMed ID: 21344920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doing the methylene shuffle--further insights into the inhibition of mitotic kinesin Eg5 with S-trityl L-cysteine.
    Abualhasan MN; Good JA; Wittayanarakul K; Anthony NG; Berretta G; Rath O; Kozielski F; Sutcliffe OB; Mackay SP
    Eur J Med Chem; 2012 Aug; 54():483-98. PubMed ID: 22749640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of L-cysteine derivatives as mitotic kinesin Eg5 inhibitors.
    Ogo N; Oishi S; Matsuno K; Sawada J; Fujii N; Asai A
    Bioorg Med Chem Lett; 2007 Jul; 17(14):3921-4. PubMed ID: 17524640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.